# Brevital Sodium

NDC: 42023-105
Generic name: methohexital sodium
Labeler / Manufacturer: Par Health USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS, RECTAL
Marketing started: 20071101

FDA application: NDA011559

## Active ingredients

- METHOHEXITAL SODIUM: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42023-105"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42023-105
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eccd8340-ead3-4363-8902-0c19d33aa2ac